All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-SARZP7 | Anti-SARS-CoV-2 (COVID-19) NP (CBN041) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN041 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP8 | Anti-SARS-CoV-2 (COVID-19) NP (CBN041) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN041 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP9 | Anti-SARS-CoV-2 (COVID-19) NP (CBN036) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN036 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP10 | Anti-SARS-CoV-2 (COVID-19) NP (CBN036) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN036 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP11 | Anti-SARS-CoV-2 (COVID-19) NP (CBN019) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN019 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP12 | Anti-SARS-CoV-2 (COVID-19) NP (CBN019) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN019 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP23 | Anti-SARS-CoV-2 (COVID-19) NP (CBN013) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN013 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP24 | Anti-SARS-CoV-2 (COVID-19) NP (CBN013) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN013 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP25 | Anti-SARS-CoV-2 (COVID-19) NP (CBN012) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN012 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP26 | Anti-SARS-CoV-2 (COVID-19) NP (CBN012) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN012 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP61 | Anti-SARS-CoV-2 (COVID-19) NP (BDI186) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | BDI186 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP62 | Anti-SARS-CoV-2 (COVID-19) NP (BDI186) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | BDI186 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP63 | Anti-SARS-CoV-2 (COVID-19) NP (3851) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | 3851 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP64 | Anti-SARS-CoV-2 (COVID-19) NP (3851) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | 3851 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP65 | Anti-SARS-CoV-2 (COVID-19) NP (3861) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | 3861 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP66 | Anti-SARS-CoV-2 (COVID-19) NP (3861) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | 3861 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP67 | Anti-SARS-CoV-2 (COVID-19) NP (BDI509) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | BDI509 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP68 | Anti-SARS-CoV-2 (COVID-19) NP (BDI509) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | BDI509 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP165 | Anti-SARS-CoV-2 (COVID-19) NP (CBFYR-0124) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBFYR-0124 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP166 | Anti-SARS-CoV-2 (COVID-19) NP (CBFYR-0124) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBFYR-0124 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION